24/7 Patient Assistance: 760-405-8205

Brian Barnett, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Brian Barnett is a top oncologist who lives and works in South San Francisco, California. He has an overall experience of more than 15 years in the medical field. He’s specialized in medical oncology and has experience in diverse areas like lung cancer, mesothelioma, laryngeal cancer breast and ovarian cancer. He graduated from the University of Mississippi School of Medicine. Dr. Brian Barnett completed his residency in internal medicine at Tulane University and a fellowship in hematologic oncology in the same institution. He gathered further experience during an internship in internal medicine at the University of Mississippi Medical Center. He brought a significant contribution to several publications that focused on the following topics: Human leukocyte antigen breast cancer, acquired factor VIII inhibitors and their management, cancer immunotherapy and the altering regulatory T cell function. Dr. Brian Barnett is currently affiliated with Ochsner Medical Center-Baton Rouge.

  • Education & Training


    University of Mississippi School of Medicine

    Medical School


    University of Mississippi Medical Center



    Tulane University



    Tulane University


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Ochsner Medical Center - Baton Rouge

    Languages: English/Spanish

    (225) 752-2470

    17000 Medical Center Dr

    Baton Rouge, Louisiana 70816

    Read More
  • Publications & Memberships

    Dr. Brian Barnett has contributed to 3 publications.

    Human leukocyte antigen g expression in breast cancer: role in immunosuppression.

    Elliott, R.L., Jiang, X.P., Phillips, J.T., Barnett, B.G., Head, J.F.; Cancer Biother Radiopharm. 2011 Apr.

    See more >>

    Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines.

    Ruter, J., Barnett, B.G., Kryczek, I., Brumlik, M.J., Daniel, B.J., Coukos, G., Zou, W., Curiel, T.J.; Front Biosci. 2009.

    See more >>

    Current management of acquired factor VIII inhibitors.

    Barnett, B.,Kruse-Jarres, R.,Leissinger, C. A.; Curr. Opin. Hematol.. 2008 Aug 13.

    See more >>